These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 15379562)

  • 21. Molecular cloning of the cDNA encoding the carboxy-terminal domain of chimpanzee apolipoprotein(a): an Asp57 --> Asn mutation in kringle IV-10 is associated with poor fibrin binding.
    Chenivesse X; Huby T; Wickins J; Chapman J; Thillet J
    Biochemistry; 1998 May; 37(20):7213-23. PubMed ID: 9585533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of plasminogen activation by lipoprotein(a): critical domains in apolipoprotein(a) and mechanism of inhibition on fibrin and degraded fibrin surfaces.
    Hancock MA; Boffa MB; Marcovina SM; Nesheim ME; Koschinsky ML
    J Biol Chem; 2003 Jun; 278(26):23260-9. PubMed ID: 12697748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure and ligand binding determinants of the recombinant kringle 5 domain of human plasminogen.
    Chang Y; Mochalkin I; McCance SG; Cheng B; Tulinsky A; Castellino FJ
    Biochemistry; 1998 Mar; 37(10):3258-71. PubMed ID: 9521645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A role for apolipoprotein(a) in protection of the low-density lipoprotein component of lipoprotein(a) from copper-mediated oxidation.
    Hill BC; Becker L; Anand V; Kusmierczyk A; Marcovina SM; Rahman MN; Gabel BR; Jia Z; Boffa MB; Koschinsky ML
    Arch Biochem Biophys; 2003 Apr; 412(2):186-95. PubMed ID: 12667482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein(a) and plasminogen interactions with fibrin: a study with recombinant apolipoprotein(a) and isolated plasminogen fragments.
    Rouy D; Koschinsky ML; Fleury V; Chapman J; Anglés-Cano E
    Biochemistry; 1992 Jul; 31(27):6333-9. PubMed ID: 1627572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Kringle V-protease domain is a fibrinogen binding region within Apo(a).
    Xue S; Madison EL; Miles LA
    Thromb Haemost; 2001 Nov; 86(5):1229-37. PubMed ID: 11816712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Features of the interaction of Glu- and Lys-forms of plasminogen with native and partially hydrolyzed fibrin].
    Grinenko TV; Skomorovskaia EV; Kudinov SA; Zolotareva EN
    Biokhimiia; 1992 May; 57(5):728-37. PubMed ID: 1322196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of lipoprotein(a) and LDL on plasminogen binding to extracellular matrix and on matrix-dependent plasminogen activation by tissue plasminogen activator.
    Pekelharing HL; Kleinveld HA; Duif PF; Bouma BN; van Rijn HJ
    Thromb Haemost; 1996 Mar; 75(3):497-502. PubMed ID: 8701415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lp(a) particles mold fibrin-binding properties of apo(a) in size-dependent manner: a study with different-length recombinant apo(a), native Lp(a), and monoclonal antibody.
    Kang C; Dominguez M; Loyau S; Miyata T; Durlach V; Anglés-Cano E
    Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1232-8. PubMed ID: 12117743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Baboon lipoprotein(a) binds very weakly to lysine-agarose and fibrin despite the presence of a strong lysine-binding site in apolipoprotein(a) kringle IV type 10.
    Belczewski AR; Ho J; Taylor FB; Boffa MB; Jia Z; Koschinsky ML
    Biochemistry; 2005 Jan; 44(2):555-64. PubMed ID: 15641780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutrophils stimulated by apolipoprotein(a) generate fragments that are stronger inhibitors of plasmin formation than apo(a).
    Lamanuzzi LB; Mtairag el M; Pepe G; Anglés-Cano E
    Thromb Haemost; 2004 Nov; 92(5):1066-75. PubMed ID: 15543335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein(a) stimulates vascular endothelial cell growth and migration and signals through integrin alphaVbeta3.
    Liu L; Craig AW; Meldrum HD; Marcovina SM; Elliott BE; Koschinsky ML
    Biochem J; 2009 Mar; 418(2):325-36. PubMed ID: 18821851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and characterization of novel lysine-independent apolipoprotein(a)-binding sites in fibrin(ogen) alphaC-domains.
    Tsurupa G; Ho-Tin-Noé B; Anglés-Cano E; Medved L
    J Biol Chem; 2003 Sep; 278(39):37154-9. PubMed ID: 12853452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrophage foam cell lipoprotein(a)/apoprotein(a) receptor. Cell-surface localization, dependence of induction on new protein synthesis, and ligand specificity.
    Keesler GA; Li Y; Skiba PJ; Fless GM; Tabas I
    Arterioscler Thromb; 1994 Aug; 14(8):1337-45. PubMed ID: 8049196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence that the conformation of unliganded human plasminogen is maintained via an intramolecular interaction between the lysine-binding site of kringle 5 and the N-terminal peptide.
    Cockell CS; Marshall JM; Dawson KM; Cederholm-Williams SA; Ponting CP
    Biochem J; 1998 Jul; 333 ( Pt 1)(Pt 1):99-105. PubMed ID: 9639568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of fibrinolysis by lipoprotein(a).
    Anglés-Cano E; de la Peña Díaz A; Loyau S
    Ann N Y Acad Sci; 2001; 936():261-75. PubMed ID: 11460483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein(a) inhibits the conversion of Glu-plasminogen to Lys-plasminogen: a novel mechanism for lipoprotein(a)-mediated inhibition of plasminogen activation.
    Feric NT; Boffa MB; Johnston SM; Koschinsky ML
    J Thromb Haemost; 2008 Dec; 6(12):2113-20. PubMed ID: 18983515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein(a), a link between atherosclerosis and tumor angiogenesis.
    Trieu VN; Uckun FM
    Biochem Biophys Res Commun; 1999 Apr; 257(3):714-8. PubMed ID: 10208849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypertriglyceridemic VLDL decreases plasminogen binding to endothelial cells and surface-localized fibrinolysis.
    Li XN; Koons JC; Benza RL; Parks JM; Varma VK; Bradley WA; Gianturco SH; Taylor KB; Grammer JR; Tabengwa EM; Booyse FM
    Biochemistry; 1996 May; 35(19):6080-8. PubMed ID: 8634250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional characterization of T7 and T8 of human apolipoprotein (a).
    Trieu VN; McConathy WJ
    Biochem Biophys Res Commun; 1998 Oct; 251(1):356-9. PubMed ID: 9790960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.